Skip to Main Content

Walgreens Boots Alliance, Inc

WBA Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of WBA by members of U.S. Congress

Politician Type Traded
Gilbert Ray Cisneros, Jr. House / D Sale $1,001 - $15,000 Feb 26, 2025
Julie Johnson House / D Sale $1,001 - $15,000 Feb 12, 2025
Julie Johnson House / D Purchase $1,001 - $15,000 Jan 15, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 02, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Jul 01, 2024
Tommy Tuberville Senate / R Sale (Full) $50,001 - $100,000 Apr 30, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Mar 25, 2024
Tommy Tuberville Senate / R Purchase $15,001 - $50,000 Mar 21, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Mar 20, 2024
Michael C. Burgess House / R Sale $1,001 - $15,000 Mar 01, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Dec 04, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 03, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Oct 10, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Oct 02, 2023
Ro Khanna House / D Sale Over $50,000,000 Sep 06, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 29, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Aug 09, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Aug 08, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Aug 08, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Aug 03, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Aug 02, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Aug 01, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Aug 01, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Jul 31, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Jul 28, 2023
Ro Khanna House / D Sale $15,001 - $50,000 Jul 28, 2023
Tommy Tuberville Senate / R Purchase $1,001 - $15,000 Jul 25, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Jun 29, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Jun 26, 2023
Tommy Tuberville Senate / R Purchase $15,001 - $50,000 Jun 13, 2023
Tommy Tuberville Senate / R Purchase $1,001 - $15,000 Jun 12, 2023
Zoe Lofgren House / D Sale $1,001 - $15,000 May 26, 2023
Ro Khanna House / D Sale $15,001 - $50,000 May 23, 2023
Tommy Tuberville Senate / R Purchase $1,001 - $15,000 May 08, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Apr 25, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Apr 17, 2023
Ro Khanna House / D Sale $15,001 - $50,000 Apr 10, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Feb 14, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Feb 10, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Nov 03, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 Sep 29, 2022
Ro Khanna House / D Sale $1,001 - $15,000 N/A
Ro Khanna House / D Sale $1,001 - $15,000 Aug 01, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 Jul 19, 2022
Ro Khanna House / D Sale $15,001 - $50,000 Jul 08, 2022
Ro Khanna House / D Sale $1,001 - $15,000 Jun 16, 2022
Ro Khanna House / D Purchase $15,001 - $50,000 May 23, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 May 10, 2022
Ro Khanna House / D Sale $1,001 - $15,000 N/A
Ro Khanna House / D Sale $1,001 - $15,000 Apr 17, 2022
WBA Stock Insider Trading Activity Follow @QuiverQuant for major insider updates
Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
WBA Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
WBA Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by WBA's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions
  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $50,000 Jul 18, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
  • $50,000 Apr 16, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
  • $50,000 Jan 19, 2025 Issue: Medicare/Medicaid Health Issues
  • $50,000 Oct 18, 2024 Issue: Labor Issues/Antitrust/Workplace Medicare/Medicaid Health Issues
  • $50,000 Jul 14, 2024 Issue: Labor Issues/Antitrust/Workplace Medicare/Medicaid Health Issues
  • $50,000 Apr 14, 2024 Issue: Medicare/Medicaid Health Issues
  • $50,000 Jan 22, 2024 Issue: None
  • $50,000 Oct 19, 2023 Issue: None
  • $60,000 Oct 17, 2023 Issue: Medicare/Medicaid Health Issues
  • $50,000 Jul 31, 2023 Issue: None
  • $50,000 Jul 19, 2023 Issue: None
  • $60,000 Jul 16, 2023 Issue: Medicare/Medicaid Health Issues
  • $50,000 Jan 20, 2023 Issue: Pharmacy
  • $60,000 Jan 17, 2023 Issue: Copyright/Patent/Trademark Budget/Appropriations Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $60,000 Oct 17, 2022 Issue: Copyright/Patent/Trademark Budget/Appropriations Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $50,000 Oct 17, 2022 Issue: None
  • $50,000 Jul 20, 2022 Issue: Pharmacy
  • $60,000 Jul 17, 2022 Issue: Copyright/Patent/Trademark Budget/Appropriations Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $50,000 Apr 19, 2022 Issue: Health Issues
  • $60,000 Apr 17, 2022 Issue: Copyright/Patent/Trademark Budget/Appropriations Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $50,000 Jan 18, 2022 Issue: Computer Industry Veterans Taxation/Internal Revenue Code
  • $60,000 Jan 16, 2022 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark
  • $50,000 Oct 20, 2021 Issue: None
  • $60,000 Oct 18, 2021 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid Budget/Appropriations
  • $50,000 Jul 20, 2021 Issue: Communications/Broadcasting/Radio/TV
  • $60,000 Jul 17, 2021 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Budget/Appropriations Health Issues
  • $60,000 Apr 17, 2021 Issue: Budget/Appropriations Health Issues Medicare/Medicaid Consumer Issues/Safety/Products Taxation/Internal Revenue Code
  • $50,000 Apr 01, 2021 Issue: None
  • $50,000 Jan 21, 2021 Issue: Health Issues
  • $60,000 Jan 19, 2021 Issue: Consumer Issues/Safety/Products Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Budget/Appropriations
  • $60,000 Oct 19, 2020 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Budget/Appropriations
  • $50,000 Oct 17, 2020 Issue: Health Issues
  • $50,000 Jul 20, 2020 Issue: Taxation/Internal Revenue Code Health Issues
  • $60,000 Jul 18, 2020 Issue: Taxation/Internal Revenue Code Budget/Appropriations Health Issues Medicare/Medicaid
  • $15,000 Apr 20, 2020 Issue: Health Issues
  • $60,000 Apr 18, 2020 Issue: Budget/Appropriations Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $10,000 Apr 10, 2020 Issue: HEALTH ISSUES
  • $60,000 Jan 19, 2020 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $15,000 Jan 02, 2020 Issue: HEALTH ISSUES
  • $15,000 Oct 22, 2019 Issue: Health Issues
  • $60,000 Oct 19, 2019 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $15,000 Jul 20, 2019 Issue: Health Issues
  • $60,000 Jul 19, 2019 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $60,000 Apr 22, 2019 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $15,000 Apr 20, 2019 Issue: Health Issues
  • $60,000 Jan 22, 2019 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
  • $23,000 Jan 22, 2019 Issue: Health Issues
  • $30,000 Oct 22, 2018 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $23,000 Oct 20, 2018 Issue: Health Issues
  • $23,000 Jul 09, 2018 Issue: Health Issues
  • $23,000 Mar 30, 2018 Issue: Health Issues
  • $23,000 Jan 13, 2018 Issue: Health Issues
  • $23,000 Oct 04, 2017 Issue: Health Issues
  • $23,000 Jul 05, 2017 Issue: Health Issues
  • $23,000 Apr 01, 2017 Issue: Health Issues
  • $23,000 Jan 23, 2017 Issue: Health Issues
  • $23,000 Oct 26, 2016 Issue: Health Issues
  • $23,000 Oct 26, 2016 Issue: Health Issues
  • $23,000 Apr 20, 2016 Issue: Health Issues
  • $36,000 Jan 19, 2016 Issue: Medicare/Medicaid
  • $36,000 Jul 22, 2015 Issue: Medicare/Medicaid
  • $36,000 Apr 07, 2015 Issue: Medicare/Medicaid
  • $36,000 Jan 14, 2015 Issue: Medicare/Medicaid
  • $36,000 Oct 08, 2014 Issue: Medicare/Medicaid
  • $36,000 Jul 18, 2014 Issue: Medicare/Medicaid
  • $36,000 Apr 19, 2014 Issue: Medicare/Medicaid
  • $36,000 Jan 21, 2014 Issue: Medicare/Medicaid
  • $36,000 Oct 15, 2013 Issue: Medicare/Medicaid
  • $36,000 Jul 18, 2013 Issue: Medicare/Medicaid
  • $36,000 Apr 10, 2013 Issue: Medicare/Medicaid
  • $36,000 Jan 16, 2013 Issue: Medicare/Medicaid
  • $36,000 Oct 19, 2012 Issue: Medicare/Medicaid
  • $30,000 Jul 18, 2012 Issue: Health Issues Medicare/Medicaid
  • $36,000 Apr 16, 2012 Issue: Health Issues
  • $36,000 Jan 12, 2012 Issue: Health Issues
  • $36,000 Oct 19, 2011 Issue: Health Issues
  • $36,000 Jul 18, 2011 Issue: Medicare/Medicaid
  • $35,000 Apr 11, 2011 Issue: Medicare/Medicaid
  • $33,000 Jan 18, 2011 Issue: Health Issues
  • $33,000 Oct 12, 2010 Issue: Health Issues
  • $33,000 Jul 16, 2010 Issue: Health Issues
  • $33,000 Apr 13, 2010 Issue: Health Issues
  • $33,000 Jan 17, 2010 Issue: Health Issues
  • $33,000 Oct 15, 2009 Issue: Health Issues
  • $33,000 Jul 09, 2009 Issue: Medicare/Medicaid
  • $33,000 Apr 03, 2009 Issue: Medicare/Medicaid
  • $33,000 Jan 16, 2009 Issue: Health Issues
  • $33,000 Oct 20, 2008 Issue: Health Issues
  • $33,000 Apr 23, 2008 Issue: Health Issues
  • $20,000 Feb 14, 2008 Issue: Pharmacy
  • $66,000 Jan 07, 2008 Issue: Medicare/Medicaid
  • $20,000 Jul 30, 2007 Issue: Pharmacy
  • $66,000 Jul 25, 2007 Issue: Medicare/Medicaid
  • $20,000 Feb 13, 2007 Issue: Pharmacy
  • $60,000 Jan 31, 2007 Issue: Health Issues
  • $60,000 Aug 21, 2006 Issue: Medicare/Medicaid
  • $20,000 Aug 14, 2006 Issue: Pharmacy
  • $20,000 Feb 09, 2006 Issue: Pharmacy
  • $40,000 Aug 05, 2005 Issue: None
  • $60,000 Jul 11, 2005 Issue: Medicare/Medicaid

Estimated quarterly lobbying spending

WBA Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
WBA Income Statement
WBA Balance Sheet
WBA Cash Flow
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded from public contracts

WBA News

Recent insights relating to WBA

CNBC Recommendations

Recent picks made for WBA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in WBA

WBA Analyst Ratings

WBA Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
WBA Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $WBA stock a Buy, Sell, or Hold?

  • What is the price target for $WBA stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

WBA Top Shareholders
Shareholder
Shares Held
WBA Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $WBA stock?

  • Who owns the most shares of $WBA stock?

  • What funds own $WBA stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

WBA Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view WBA Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top